September 28, 2015

Mylan’s latest generic, recently approved by the Food and Drug Administration, is intended to treat schizophrenia and schizoaffective disorder.

September 22, 2015

Impax Laboratories announced Tuesday that the Food and Drug Administration had approved its generic of Valeant’s Testred (methyltestosterone) capsules.

September 21, 2015

This is Impax’s first drug to be approved following its Sept. 4 resolution of issues outlined by the FDA in a warning letter to the company.

September 17, 2015

Aurobindo Pharma’s received approval from the Food and Drug Administration this week for its generic of Roxane Laboratories’ Dolophine (methadone HCL) tablets. 

September 10, 2015

Purdue Pharma this week announced that it had VM902A, acquired an allosteric selective tropmyosin receptor kinase A (TrkA) inhibitor, from VM Pharma.

September 4, 2015

AstraZeneca on Thursday announced that the Food and Drug Administration approved Brilinta (ticagrelor) tablets at a 60 mg dose for patients with a history of heart attack beyond the first year.

August 28, 2015

Amgen announced Friday that the Food and Drug Administration had approved its new cholesterol treatment Repatha (evolocumab) injection.

August 28, 2015

The Food and Drug Administration has a new diabetes treatment developed by Boehringer Ingelheim Pharmaceuticals and Eli Lilly and Co.

August 25, 2015

Glucose monitoring device company Dexcom announced Tuesday that the Food and Drug Administration had approved its G5 Mobile Continuous Glucose Monitoring System.

August 10, 2015

Experts from the CVS Health Research Institute, writing today in the Journal of the American Medical Association, are calling for a reconsideration of treatment guidelines for high cholesterol as PCSK9 inhibitors hit the market.

August 10, 2015

The Food and Drug Administration approved Mylan's Lidocaine Patch 5%, a generic version of Endo Pharmaceutical's Lidoderm.

August 10, 2015

The company’s memantine hydrochloride tablets, available in 5- and 10-mg dosage strengths, are meant to treat dementia associated with Alzheimer’s disease.

July 27, 2015

As the sole U.S. supplier of fluoxymesterone, Upsher-Smith sought a way to renew the product’s availability after the company’s initial API manufacturer discontinued its supply. 

July 23, 2015

Verde Technologies this week is debuting its Deterra Drug Deactivation System, a self-contained pouch used to dispose of prescription medications.

July 16, 2015

Galderma Laboratories announced Thursday that the Food and Drug Administration had approved it Epiduo Forte Gel, an antibiotic-free daily treatment for acne vulgaris.

July 14, 2015

During the 2013-2014 season, the CDC estimated influenza vaccination prevented 7.2 million influenza-associated illnesses, 3.1 million medically attended illnesses and 90,000 hospitalizations.

July 8, 2015

Flublok is the only flu vaccine made in a 100% egg-free system using modern cell culture technology, which speeds production to market. 

June 24, 2015

Aurobindo Pharma Limited has announced that it has received final approval from the U.S. Food and Drug Administration for entacapone tablets USP, 200 mg, the generic equivalent to Comtan Tablets 200 mg.

June 23, 2015

Pfizer has entered into an agreement with GlaxoSmithKline to acquire its quadrivalent meningitis ACWY vaccines, Nimenrix and Mencevax, for approximately $130 million.

June 2, 2015
Aurobindo Pharma Limited has received approval from the Food and Drug Administration for its generic equivalent to Flagyl (metronidazole) tablets in 250- and 500-mg dosage strengths.  
 
April 1, 2015

The recently Food and Drug Administration-approved AirStrip Sense4Baby monitoring system will enable remote self-administered non-stress tests as part of a comprehensive prenatal care model. 

March 30, 2015

Teva Pharmaceutical Industries and Auspex Pharmaceuticals announced an agreement under which Teva will acquire Auspex in a deal valued at $3.2 billion.